Toremifene in Treating Patients With Desmoid Tumors

Completed · Phase 2

Conditions studied: Desmoid Tumor

In brief

RATIONALE: Estrogen can stimulate the growth of cancer cells. Hormone therapy using toremifene may fight the growth of desmoid tumors by reducing the production of estrogen. PURPOSE: Phase II trial to study the effectiveness of toremifene in treating patients with desmoid tumors.

Key facts

Study ID

NCT00002595

Run by

Advocate Lutheran General Hospital

People needed

72

Starts

1991-07-01

Expected to finish

2010-09-01

Last updated by the study team

2013-07-10

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Lutheran General Hospital — Park Ridge, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.